The Department of Health and Human Services has a new plan to cut drug spending. President Trump claims this reform marks "a revolutionary change" for American patients.
He's right, but it's not a change for the better, which is why Senate Finance Committee Chairman Chuck Grassley (R-Iowa) recently announced he opposes the plan, claiming it would hurt innovation.
